TABUTEAU HERRIOT
CIK 1219927
Transactions on file
26
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | 2026-06-09 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 49,670 | $11.97M | +5.9% | open → |
| 2026-06-09 | 2026-06-09 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 49,670 | $245.9K | +5054.9% | open → |
| 2025-12-04 | 2025-12-04 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 10,558 | $1.56M | +72.2% | open → |
| 2025-12-04 | 2025-12-04 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 10,558 | $84.7K | +3081.7% | open → |
| 2025-12-04 | 2025-12-03 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 20,163 | $2.96M | +73.7% | open → |
| 2025-12-04 | 2025-12-03 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 20,163 | $161.7K | +3081.7% | open → |
| 2025-12-04 | 2025-12-02 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 49,252 | $7.12M | +76.5% | open → |
| 2025-12-04 | 2025-12-02 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 49,252 | $395.0K | +3081.7% | open → |
| 2025-11-05 | 2025-11-05 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 21,775 | $2.93M | +89.7% | open → |
| 2025-11-05 | 2025-11-05 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 21,775 | $174.6K | +3081.7% | open → |
| 2025-11-05 | 2025-11-04 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 50,459 | $6.75M | +90.7% | open → |
| 2025-11-05 | 2025-11-04 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 50,459 | $404.7K | +3081.7% | open → |
| 2025-11-05 | 2025-11-03 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 91,705 | $12.14M | +92.8% | open → |
| 2025-11-05 | 2025-11-03 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 91,705 | $735.5K | +3081.7% | open → |
| 2025-10-08 | 2025-10-08 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 12,774 | $1.52M | +114.7% | open → |
| 2025-10-08 | 2025-10-08 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 12,774 | $102.4K | +3081.7% | open → |
| 2025-10-08 | 2025-10-07 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 13,390 | $1.59M | +114.8% | open → |
| 2025-10-08 | 2025-10-07 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 13,390 | $107.4K | +3081.7% | open → |
| 2025-10-08 | 2025-10-06 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Sale | 19,220 | $2.31M | +112.3% | open → |
| 2025-10-08 | 2025-10-06 | AXSM Axsome Therapeutics, Inc. | Chief Executive Officer | Exer. | 19,220 | $154.1K | +3081.7% | open → |
| 2025-09-16 | 2025-09-16 | AXSM Axsome Therapeutics, Inc. | OfficerDirector10% Chief Executive Officer | Exer. | 19,719 | $158.1K | +3081.7% | open → |
| 2025-09-16 | 2025-09-16 | AXSM Axsome Therapeutics, Inc. | OfficerDirector10% Chief Executive Officer | Sale | 19,719 | $2.25M | +123.5% | open → |
| 2025-09-16 | 2025-09-12 | AXSM Axsome Therapeutics, Inc. | OfficerDirector10% Chief Executive Officer | Exer. | 27,907 | $223.8K | +3081.7% | open → |
| 2025-09-16 | 2025-09-12 | AXSM Axsome Therapeutics, Inc. | OfficerDirector10% Chief Executive Officer | Sale | 27,907 | $3.32M | +114.5% | open → |
| 2025-09-16 | 2025-09-15 | AXSM Axsome Therapeutics, Inc. | OfficerDirector10% Chief Executive Officer | Exer. | 15,254 | $122.3K | +3081.7% | open → |
| 2025-09-16 | 2025-09-15 | AXSM Axsome Therapeutics, Inc. | OfficerDirector10% Chief Executive Officer | Sale | 15,254 | $1.79M | +117.4% | open → |
